Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis
Research
[키워드] 95% CI
95% confidence interval
acute respiratory distress
age
analyzed
Antiviral treatment
ARDS
ARDS patient
calculate
caused
CIs
Clinical practice
Cohort
cohort study
Comorbidities
coronavirus disease
Coronavirus disease 2019
Corticosteroid
corticosteroid therapy
corticosteroid treatment
Corticosteroids
COVID-19
COVID-19 patient
Cox regression analysis
Cox regression model
dose
enrolled
hazard ratio
Hospital admission
HRs
In-hospital death
in-hospital mortality
Invasive mechanical ventilation
IQR
low-dose corticosteroid
median
Methylprednisolone
Mortality
Organ failure
outcome
Patient
patients with ARDS
per day
Primary outcome
Propensity score
propensity score analysis
reduced risk
reduction in
Respiratory Support
Result
retrospective
risk
risk of death
severe acute respiratory syndrome coronavirus 2
Sex
single-center
SOFA
SOFA score
standard treatment
systemic corticosteroid
therapy
Treatment
viral RNA clearance
were used
[DOI] 10.1186/s13054-020-03340-4 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13054-020-03340-4 PMC 바로가기 [Article Type] Research